Substance abuse
Introduction
According to the WHO ATLAS globally 3.5%–5.7% of 15–64 year olds reportedly use illicit drugs. Between 10% and 15% of these people are estimated to develop dependence or a pattern of harmful use. In the Eastern Mediterranean Region prevalence of drug use disorders is estimated to be 3500 per 100 000 population and that of injecting drug use is 172 per 100 000 accounting for a loss of 4 disability-adjusted life years (DALYs) and 9 deaths per 1000 population, compared with the loss of 2 DALYs and 4 deaths per 1000 population globally.
The WHO mental health and substance abuse programme provides technical support to Member States to develop evidence-informed policies, plans and legislation; promote the most effective prevention, care and treatment services for substance use disorders, including long-term maintenance programmes which replace opioids with opioid-like (or agonist) substances, and integrate these services into primary care health systems.
Information resources
Recent publications
Self-help strategies for cutting down or stopping substance use: a guide [pdf 2.23 MB]
Policy documents
mhGAP: Mental Health Gap Action Programme: scaling up care for mental, neurological and substance use disorders [pdf 804 KB] | Arabic [pdf 804 KB]
Strategy for mental health and substance abuse in the Eastern Mediterranean Region 2012–2016 [pdf 52 KB] | Arabic [pdf 52 KB] | French [pdf 52 KB]
Technical paper Maternal, child and adolescent mental health: challenges and strategic directions 2010–2015 [pdf 88 KB] | Arabic [pdf 88 KB] l French [pdf 88 KB]
Links
Cochrane Drugs and Alcohol Group
European Monitoring Centre for Drugs and Drug Addiction
International network on Brief Intervention for Alcohol Problems
Middle East & North Africa Harm Reduction (MENAHRA)
Related topics
Psychosis, including schizophrenia
Related programmes
AIDS and sexually transmitted diseases
Health education and promotion
Violence, injuries and disability
Collaborating centres
WHO Collaborating Centre for Mental Health, Psychiatric Centre, Ibn Rushd University
WHO Collaborating Centre for Research and Training in Mental Health
WHO Collaborating Centre for Mental Health Research, Training and Substance Abuse
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence [pdf 1.08 MB]
The Alcohol, Smoking and Substance involvement Screening Test (ASSIST): manual for use in primary care [pdf 1.50 MB]
The ASSIST-linked brief intervention for hazardous and harmful substance use: a manual for use in primary care[pdf 1.12 MB]